1. Home
  2. CYTH vs DTCK Comparison

CYTH vs DTCK Comparison

Compare CYTH & DTCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • DTCK
  • Stock Information
  • Founded
  • CYTH 1990
  • DTCK 1999
  • Country
  • CYTH United States
  • DTCK Singapore
  • Employees
  • CYTH N/A
  • DTCK N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • DTCK Farming/Seeds/Milling
  • Sector
  • CYTH Health Care
  • DTCK Industrials
  • Exchange
  • CYTH Nasdaq
  • DTCK Nasdaq
  • Market Cap
  • CYTH 35.5M
  • DTCK 31.1M
  • IPO Year
  • CYTH N/A
  • DTCK 2023
  • Fundamental
  • Price
  • CYTH $1.21
  • DTCK $1.15
  • Analyst Decision
  • CYTH Strong Buy
  • DTCK
  • Analyst Count
  • CYTH 3
  • DTCK 0
  • Target Price
  • CYTH $3.20
  • DTCK N/A
  • AVG Volume (30 Days)
  • CYTH 27.4K
  • DTCK 150.5K
  • Earning Date
  • CYTH 08-12-2024
  • DTCK 07-09-2024
  • Dividend Yield
  • CYTH N/A
  • DTCK N/A
  • EPS Growth
  • CYTH N/A
  • DTCK 100.00
  • EPS
  • CYTH N/A
  • DTCK 0.04
  • Revenue
  • CYTH $1,126,444.00
  • DTCK $190,724,000.00
  • Revenue This Year
  • CYTH $28.30
  • DTCK N/A
  • Revenue Next Year
  • CYTH $14.19
  • DTCK N/A
  • P/E Ratio
  • CYTH N/A
  • DTCK $29.23
  • Revenue Growth
  • CYTH N/A
  • DTCK 44.90
  • 52 Week Low
  • CYTH $0.89
  • DTCK $0.76
  • 52 Week High
  • CYTH $2.12
  • DTCK $9.00
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 45.15
  • DTCK 47.89
  • Support Level
  • CYTH $1.13
  • DTCK $0.85
  • Resistance Level
  • CYTH $1.28
  • DTCK $1.29
  • Average True Range (ATR)
  • CYTH 0.07
  • DTCK 0.17
  • MACD
  • CYTH -0.01
  • DTCK -0.01
  • Stochastic Oscillator
  • CYTH 5.00
  • DTCK 56.01

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Share on Social Networks: